- 2017
- News in brief - 07.04.2017
Depression, cardiovascular risk… and the class struggle
Depression is not just one of the world’s most incapacitating illnesses – it also comes with an increased risk of cardiovascular disease, particularly that of the coronary arteries (angina and heart attack). According to a study by Inserm conducted in 10,000 people followed up for more than 20 years, this risk is doubled in non-executive or blue-collar […]
- Press releases - 06.04.2017
Ebola: New trial launched in West Africa to evaluate three vaccination strategies
The French National Institute of Health and Medical Research (Inserm), the US National Institutes of Health (NIH) and the London School of Hygiene & Tropical Medicine (LSHTM), in collaboration with health authorities in Guinea and Liberia, are launching a large clinical trial of candidate Ebola vaccines under the aegis of the PREVAC international consortium (Partnership for Research on Ebola VACcination).
- Press releases - 05.04.2017
New step towards the treatment of myotubular myopathy: gene therapy restores strength and prolongs lives in affected dogs
A team of researchers in France, led by Dr. Ana Buj-Bello (Genethon/Inserm) and teams at the University of Washington and Harvard Medical School in the United States, achieved a new step towards the treatment of myotubular myopathy by gene therapy. The researchers demonstrated the efficacy of administration of a therapeutic vector by a single intravenous injection and identified the dose that restores long-term muscular strength in a large animal model of the disease.
- Press releases - 04.04.2017
Action on dietary behaviours, a collective expert review by Inserm
Le rôle des facteurs nutritionnels (alimentation et activité physique) dans le développement du surpoids et de l’obésité et dans la survenue de nombreuses maladies chroniques telles que les cancers, les maladies cardiovasculaires, le diabète et l’arthrose est à ce jour scientifiquement bien établi. Ces maladies constituent la première cause de mortalité à l’échelle de la planète et le nombre de patients concernés ne cesse d’augmenter.
- What's on? - 03.04.2017
Friday 7 April: World Health Day 2017, focus on depression
Each year on the same date, so as to mark the date of its creation, the World Health Organisation alerts politicians and the media to a public health problem. This year it is depression which is in the spotlight. This affects individuals of any age from any country in the world. If depression can be […]
- Press releases - 03.04.2017
High-throughput genomic analyses enhance cancer prognosis !
In a study published on 1 April 2017 in the prestigious journal Cancer Discovery, research teams at Gustave Roussy, Inserm and Paris-Sud University demonstrate that analysing the molecular portrait of a malignant tumour makes it possible to identify the appropriate therapy and improve the prognosis of patients with cancer. MOSCATO, the biggest precision medicine study conducted to date, proves it for the first time.
- Press releases - 31.03.2017
Decision-making, a contagious process
Les individus apprennent à évaluer le niveau de prudence, de patience ou de fainéantise dont font preuve les autres après avoir observé leur comportement, mais surtout, cela influe sur leurs propres décisions, sans même qu’ils s’en rendent compte. Une découverte qui pourrait avoir des retombées en neurosciences. Les décisions de nos voisins inspirent-elles les nôtres ? C’est ce que laissent entendre les travaux de Jean Daunizeau et Marie Devaine, deux chercheurs Inserm à l’Institut du Cerveau et de la Moelle épinière à Paris (Inserm/ CNRS/ UPMC). Ils ont étudié le comportement de personnes soumises à des choix faisant appel à la prudence, la patience ou l’effort et montrent qu’après avoir observé le comportement d’autres individus, elles se mettent à les imiter, sans même s’en rendre compte !
- Press releases - 29.03.2017
Sunday 2 April: World Autism Awareness Day
On 2 April, World Autism Awareness Day takes place with the aim of raising awareness and better informing the general public on the realities of this development disorder.
Autism is a pervasive developmental disorder that appears during childhood and continues into adulthood. It presents as an altered ability to establish social interactions and communicate, and as behavioural problems.France has about 100 young people under 20 who have Pervasive Developmental Disorder (PDD). Childhood autism affects about 30,000 of them
- What's on? - 29.03.2017
Sunday 2 April: World Autism Awareness Day
On 2 April, World Autism Awareness Day takes place with the aim of raising awareness and better informing the general public on the realities of this development disorder. Autism is a pervasive developmental disorder that appears during childhood and continues into adulthood. It presents as an altered ability to establish social interactions and communicate, and […]
- News in brief - 28.03.2017
Measuring gray matter to predict recovery from coma
Predicting recovery from coma following cardiac arrest remains a question to which physicians do not have an exact response. When – and if – a critical care patient will recover consciousness is evaluated essentially by means of recurrent clinical examinations and the recording of brain activity. Researchers at Inserm (Inserm Unit 1214 Toulouse NeuroImaging Center) […]